EDWARDS LIFESCIENCES CORP
NYSE: EW (Edwards Lifesciences Corporatio)
Last update: 1 hour ago85.21
0.97 (1.15%)
| Previous Close | 84.24 |
| Volume | 3,890,411 |
| Price / Earnings (Forward) | 25.64 |
| Price / Sales | 7.75 |
| Price / Book | 4.71 |
| 52 Weeks Range |
| Profit Margin | 75.71% |
| Operating Margin (TTM) | 29.01% |
| Diluted EPS (TTM) | 2.42 |
| Quarterly Revenue Growth (YOY) | 6.20% |
| Quarterly Earnings Growth (YOY) | 1.70% |
| Total Debt/Equity (MRQ) | 6.86% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 876.20 M |
| Levered Free Cash Flow (TTM) | 1.45 B |
| Return on Assets (TTM) | 8.42% |
| Return on Equity (TTM) | 16.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Edwards Lifesciences Corporatio | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | -0.75 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.91% |
| % Held by Institutions | 89.29% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Jpmorgan Chase & Co | 30 Jun 2026 | 22,783,175 |
| Bank Of New York Mellon Corp | 30 Jun 2026 | 14,084,483 |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt | 30 Jun 2026 | 13,002,965 |
| Ninety One Uk Ltd | 30 Jun 2026 | 12,337,502 |
| Aristotle Capital Management, Llc | 30 Jun 2026 | 8,665,712 |
| Alliancebernstein L.P. | 30 Jun 2026 | 8,660,416 |
| Fmr Llc | 30 Jun 2026 | 8,435,949 |
| Norges Bank | 30 Jun 2026 | 8,373,783 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |